A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 1-2, 2015, Pages 124-126

  Oskarsson, Björn ^a   Wheelock, Victoria ^a   Benatar, Michael ^b   Taylor, J Paul ^c   Joyce, Nanette ^a   Chesak, David ^d   Jin, Lee Way ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Sutter Neuroscience Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; ARTICLE; BRAIN WEIGHT; BREATHING MUSCLE; CASE REPORT; CHOREA; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DYSARTHRIA; FAMILY HISTORY; FASCICULATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MICROSCOPY; MIDDLE AGED; MONTREAL COGNITIVE ASSESSMENT; MULTISYSTEM PROTEINOPATHY; MUSCLE ATROPHY; MUSCLE WEAKNESS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SACCADIC EYE MOVEMENT; SUBSTANTIA NIGRA; TENDON REFLEX; BRAIN; COMPLICATION; METABOLISM; NERVE CELL; PATHOLOGY; TDP 43 PROTEINOPATHY;

GLIAL FIBRILLARY ACIDIC PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEURONS; TDP-43 PROTEINOPATHIES;

EID: 84925688649     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.952238     Document Type: Article

References (9)

1. Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, et al. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology. 2013; 80: 1874-80.
2. Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013; 78: 65-80.
3. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010; 68: 857-64.
4. La Spada AR, Weydt P, Pineda VV. Huntington Disease Pathogenesis: Mechanisms and Pathways. 2011.
5. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Hunt-ington disease. Journal of Neuropathology and Experimental Neurology. 1985; 44: 559-77.
6. Rubio A, Steinberg K, Figlewicz DA, MacDonald ME, Greenamyre T, Hamill R, et al. Coexistence of Huntington disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathologica. 1996; 92: 421-7.
7. Rinaldi C, Salvatore E, Giordano I, de Matteis S, Tucci T, Cinzia VR, et al. Predictors of survival in a Huntington disease population from southern Italy. Can J Neurol Sci. 2012; 39: 48-51.
8. Ju JS, Miller SE, Hanson PI, Weihl CC. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem. 2008; 283: 30289-99.
9. Poksay KS, Madden DT, Peter AK, Niazi K, Banwait S, Crippen D, et al. Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration. J Mol Neurosci. 2011; 44: 91-102.